NL1025542A1 - Geanelleerde heteroarylcarbonzuren als PPAR-agonisten. - Google Patents
Geanelleerde heteroarylcarbonzuren als PPAR-agonisten.Info
- Publication number
- NL1025542A1 NL1025542A1 NL1025542A NL1025542A NL1025542A1 NL 1025542 A1 NL1025542 A1 NL 1025542A1 NL 1025542 A NL1025542 A NL 1025542A NL 1025542 A NL1025542 A NL 1025542A NL 1025542 A1 NL1025542 A1 NL 1025542A1
- Authority
- NL
- Netherlands
- Prior art keywords
- fused
- ppar agonists
- heteroarylcarboxylic acids
- heteroarylcarboxylic
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44893103P | 2003-02-21 | 2003-02-21 | |
US44893103 | 2003-02-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
NL1025542A1 true NL1025542A1 (nl) | 2004-08-24 |
NL1025542C2 NL1025542C2 (nl) | 2005-10-11 |
Family
ID=32908672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL1025542A NL1025542C2 (nl) | 2003-02-21 | 2004-02-20 | Geanelleerde heteroarylcarbonzuren als PPAR-agonisten. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040209929A1 (nl) |
EP (1) | EP1597257A1 (nl) |
JP (1) | JP2006518366A (nl) |
AR (1) | AR044498A1 (nl) |
BR (1) | BRPI0407735A (nl) |
CA (1) | CA2516475A1 (nl) |
GT (1) | GT200400019A (nl) |
MX (1) | MXPA05008922A (nl) |
NL (1) | NL1025542C2 (nl) |
PA (1) | PA8594401A1 (nl) |
PE (1) | PE20050223A1 (nl) |
TW (1) | TW200424201A (nl) |
UY (1) | UY28200A1 (nl) |
WO (1) | WO2004074284A1 (nl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1692506A4 (en) * | 2003-11-17 | 2008-01-09 | Janssen Pharmaceutica Nv | MODELING A SYSTEMIC INFLAMMATORY RESPONSE TO INFECTION |
US20050203151A1 (en) * | 2003-12-19 | 2005-09-15 | Kalypsys, Inc. | Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions |
CA2576993C (en) * | 2004-08-12 | 2013-09-24 | Amgen Inc. | Bisaryl-sulfonamides |
EP1794159B1 (en) | 2004-09-11 | 2012-08-01 | Sanofi-Aventis Deutschland GmbH | 7-azaindoles and their use as ppar agonists |
WO2006053342A2 (en) * | 2004-11-12 | 2006-05-18 | Osi Pharmaceuticals, Inc. | Integrin antagonists useful as anticancer agents |
PE20080188A1 (es) * | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol |
MX2011004125A (es) * | 2008-10-21 | 2011-05-19 | Metabolex Inc | Agonistas del receptor gpr120 de arilo y usos de los mismos. |
TWI667233B (zh) | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | 新穎吲唑羧醯胺,其製備方法、含彼等之醫藥製劑及其製造醫藥之用途 |
JP6369951B2 (ja) * | 2015-08-26 | 2018-08-08 | 三井農林株式会社 | ジペプチジルペプチダーゼ−iv阻害剤 |
WO2017121308A1 (en) * | 2016-01-11 | 2017-07-20 | Chongqing Fochon Pharmaceutical Co., Ltd. | Fused pyridine compounds, compositions and methods of use |
WO2018202039A1 (zh) * | 2017-05-03 | 2018-11-08 | 成都海创药业有限公司 | 杂环化合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420289A (en) * | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
EP0787725B1 (en) * | 1994-10-20 | 2003-04-23 | Nippon Chemiphar Co., Ltd. | Quinoline derivative |
PL356769A1 (en) * | 1999-12-03 | 2004-07-12 | Kyoto Pharmaceutical Industries, Ltd. | Novel heterocyclic compounds and salts thereof and medicinal use of the same |
US6924295B2 (en) * | 2001-06-18 | 2005-08-02 | Ono Pharmaceutical Co., Ltd. | Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
HUP0401620A2 (hu) * | 2001-08-29 | 2004-11-29 | Warner-Lambert Company Llc | Orális antidiabetikus hatóanyagok és eljárás előállításukra |
US20030171377A1 (en) * | 2001-08-29 | 2003-09-11 | Bigge Christopher Franklin | Antidiabetic agents |
-
2004
- 2004-01-22 PA PA20048594401A patent/PA8594401A1/es unknown
- 2004-02-09 EP EP04709295A patent/EP1597257A1/en not_active Withdrawn
- 2004-02-09 MX MXPA05008922A patent/MXPA05008922A/es unknown
- 2004-02-09 WO PCT/IB2004/000338 patent/WO2004074284A1/en not_active Application Discontinuation
- 2004-02-09 JP JP2006502422A patent/JP2006518366A/ja active Pending
- 2004-02-09 BR BRPI0407735-0A patent/BRPI0407735A/pt not_active Application Discontinuation
- 2004-02-09 CA CA002516475A patent/CA2516475A1/en not_active Abandoned
- 2004-02-18 PE PE2004000169A patent/PE20050223A1/es not_active Application Discontinuation
- 2004-02-18 GT GT200400019A patent/GT200400019A/es unknown
- 2004-02-19 UY UY28200A patent/UY28200A1/es not_active Application Discontinuation
- 2004-02-19 US US10/783,654 patent/US20040209929A1/en not_active Abandoned
- 2004-02-20 NL NL1025542A patent/NL1025542C2/nl not_active IP Right Cessation
- 2004-02-20 TW TW093104303A patent/TW200424201A/zh unknown
- 2004-02-20 AR ARP040100541A patent/AR044498A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW200424201A (en) | 2004-11-16 |
GT200400019A (es) | 2004-09-21 |
NL1025542C2 (nl) | 2005-10-11 |
MXPA05008922A (es) | 2005-10-05 |
JP2006518366A (ja) | 2006-08-10 |
WO2004074284A1 (en) | 2004-09-02 |
PA8594401A1 (es) | 2004-09-16 |
PE20050223A1 (es) | 2005-03-22 |
US20040209929A1 (en) | 2004-10-21 |
EP1597257A1 (en) | 2005-11-23 |
BRPI0407735A (pt) | 2006-02-14 |
UY28200A1 (es) | 2004-09-30 |
CA2516475A1 (en) | 2004-09-02 |
AR044498A1 (es) | 2005-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL1026826A1 (nl) | Gesubstitueerde pyridinonen. | |
NL1026776A1 (nl) | Antilichamen tegen c-MET. | |
NL1025946A1 (nl) | Alfa-gesubstitueerde carbonzuren als PPAR-modulatoren. | |
NO20054957D0 (no) | Subtituerte karboksylsyrer | |
DK1689775T3 (da) | GAG-bindende proteiner | |
NL1024881A1 (nl) | PPAR-activatoren. | |
NO20053753D0 (no) | Karboksylsyreforbindelser. | |
NO20051500D0 (no) | Substituerte heterocyklylpyrimidiner. | |
NL1025542A1 (nl) | Geanelleerde heteroarylcarbonzuren als PPAR-agonisten. | |
NL1024983A1 (nl) | Morfolinen als dopamineagonisten. | |
FR2855029B1 (fr) | Cache-pot. | |
ITMI20031078A1 (it) | Copridivano. | |
ITGE20030068A1 (it) | Termoalgometro. | |
ES1056270Y (es) | Conmutador universal. | |
NL1022317A1 (nl) | Koppelstuk. | |
DE60335380D1 (de) | Muskarine agonisten | |
ES1055830Y (es) | Mosquitera. | |
ITLE20020021A1 (it) | Fuma meno. | |
ES1056347Y (es) | Alzador de faldas. | |
NL1024080A1 (nl) | Koppelstuk. | |
ES1055245Y (es) | Identificador mejorado. | |
ES1055925Y (es) | Portaprecios perfeccionado. | |
ES1056403Y (es) | Flotador perfeccionado. | |
ES1053801Y (es) | Salvavidas perfeccionado. | |
ITBO20030604A1 (it) | Apparato di profumazione ambientale. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AD1A | A request for search or an international type search has been filed | ||
RD2N | Patents in respect of which a decision has been taken or a report has been made (novelty report) |
Effective date: 20050610 |
|
PD2B | A search report has been drawn up | ||
VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20080901 |